Long-Term Clinical effects of intermittent intravenous cyclophosphamide on severe lupus nephritis

Kuan-Hsun Wu, Y. S. Dai, Ming Jer Tsai, Shih Chiang Lin, Ling Hua Wang, Miao Tsu Huang, Bor Luen Chiang

Research output: Contribution to journalArticle

Abstract

This long-term follow-up study evaluates the clinical efficacy, toxicity, and effects on renal histopathology of intravenous high dose cyclophosphamide (IVCY) therapy for severe active lupus nephritis patients. The clinical course and final outcome for each patient was evaluted by determining daily oral prednisolone dose. C3, C4, anti-dsDNA, Ccr, daily urine protein, serum albumin, hemoglobulin, blood urea nitrogen, creatinine and renal histopathology. This regimen resulted in significant improvement of daily prednisolone dosage, serum C3, C4, albumin, hemoglobulin and Ccr as early as the third month, and became further improved or stable through 24 months. The mean anti-dsDNA level, twenty-four-hour urine protein excretion, and serum urea nitrogen level showed statistical decrease at variable time course and there were no statistical changes in the serum creatinine level throughout this study. Renal biopsies were obtained in 10 out-of 11 patients at the beginning of treatment, and follow-up renal biopsies were performed in 7 out of 10 patients, and five patients showed improvement in histologic features and had predominent Class II. Even this was an retrospective and uncontrolled study, intermittent IVCY therapy seemed to be an effective regimen for severe lupus nephritis. However, further investigation and regular follow-up are necessary to elucidate the long-term effects and complications of IVCY therapy.
Original languageEnglish
Pages (from-to)27-34
Number of pages8
JournalJournal of Microbiology, Immunology and Infection
Volume31
Issue number1
Publication statusPublished - 1998

Fingerprint

Lupus Nephritis
Cyclophosphamide
Kidney
Prednisolone
Creatinine
Urine
Biopsy
Blood Urea Nitrogen
Therapeutics
Serum
Serum Albumin
Urea
Blood Proteins
Albumins
Nitrogen
Retrospective Studies
Proteins

Cite this

Wu, K-H., Dai, Y. S., Tsai, M. J., Lin, S. C., Wang, L. H., Huang, M. T., & Chiang, B. L. (1998). Long-Term Clinical effects of intermittent intravenous cyclophosphamide on severe lupus nephritis. Journal of Microbiology, Immunology and Infection, 31(1), 27-34.

Long-Term Clinical effects of intermittent intravenous cyclophosphamide on severe lupus nephritis. / Wu, Kuan-Hsun; Dai, Y. S.; Tsai, Ming Jer; Lin, Shih Chiang; Wang, Ling Hua; Huang, Miao Tsu; Chiang, Bor Luen.

In: Journal of Microbiology, Immunology and Infection, Vol. 31, No. 1, 1998, p. 27-34.

Research output: Contribution to journalArticle

Wu, Kuan-Hsun ; Dai, Y. S. ; Tsai, Ming Jer ; Lin, Shih Chiang ; Wang, Ling Hua ; Huang, Miao Tsu ; Chiang, Bor Luen. / Long-Term Clinical effects of intermittent intravenous cyclophosphamide on severe lupus nephritis. In: Journal of Microbiology, Immunology and Infection. 1998 ; Vol. 31, No. 1. pp. 27-34.
@article{454feff77aca4266bcef1c7b3a2d5680,
title = "Long-Term Clinical effects of intermittent intravenous cyclophosphamide on severe lupus nephritis",
abstract = "This long-term follow-up study evaluates the clinical efficacy, toxicity, and effects on renal histopathology of intravenous high dose cyclophosphamide (IVCY) therapy for severe active lupus nephritis patients. The clinical course and final outcome for each patient was evaluted by determining daily oral prednisolone dose. C3, C4, anti-dsDNA, Ccr, daily urine protein, serum albumin, hemoglobulin, blood urea nitrogen, creatinine and renal histopathology. This regimen resulted in significant improvement of daily prednisolone dosage, serum C3, C4, albumin, hemoglobulin and Ccr as early as the third month, and became further improved or stable through 24 months. The mean anti-dsDNA level, twenty-four-hour urine protein excretion, and serum urea nitrogen level showed statistical decrease at variable time course and there were no statistical changes in the serum creatinine level throughout this study. Renal biopsies were obtained in 10 out-of 11 patients at the beginning of treatment, and follow-up renal biopsies were performed in 7 out of 10 patients, and five patients showed improvement in histologic features and had predominent Class II. Even this was an retrospective and uncontrolled study, intermittent IVCY therapy seemed to be an effective regimen for severe lupus nephritis. However, further investigation and regular follow-up are necessary to elucidate the long-term effects and complications of IVCY therapy.",
author = "Kuan-Hsun Wu and Dai, {Y. S.} and Tsai, {Ming Jer} and Lin, {Shih Chiang} and Wang, {Ling Hua} and Huang, {Miao Tsu} and Chiang, {Bor Luen}",
year = "1998",
language = "English",
volume = "31",
pages = "27--34",
journal = "Journal of Microbiology, Immunology and Infection",
issn = "0253-2662",
publisher = "Elsevier Taiwan LLC",
number = "1",

}

TY - JOUR

T1 - Long-Term Clinical effects of intermittent intravenous cyclophosphamide on severe lupus nephritis

AU - Wu, Kuan-Hsun

AU - Dai, Y. S.

AU - Tsai, Ming Jer

AU - Lin, Shih Chiang

AU - Wang, Ling Hua

AU - Huang, Miao Tsu

AU - Chiang, Bor Luen

PY - 1998

Y1 - 1998

N2 - This long-term follow-up study evaluates the clinical efficacy, toxicity, and effects on renal histopathology of intravenous high dose cyclophosphamide (IVCY) therapy for severe active lupus nephritis patients. The clinical course and final outcome for each patient was evaluted by determining daily oral prednisolone dose. C3, C4, anti-dsDNA, Ccr, daily urine protein, serum albumin, hemoglobulin, blood urea nitrogen, creatinine and renal histopathology. This regimen resulted in significant improvement of daily prednisolone dosage, serum C3, C4, albumin, hemoglobulin and Ccr as early as the third month, and became further improved or stable through 24 months. The mean anti-dsDNA level, twenty-four-hour urine protein excretion, and serum urea nitrogen level showed statistical decrease at variable time course and there were no statistical changes in the serum creatinine level throughout this study. Renal biopsies were obtained in 10 out-of 11 patients at the beginning of treatment, and follow-up renal biopsies were performed in 7 out of 10 patients, and five patients showed improvement in histologic features and had predominent Class II. Even this was an retrospective and uncontrolled study, intermittent IVCY therapy seemed to be an effective regimen for severe lupus nephritis. However, further investigation and regular follow-up are necessary to elucidate the long-term effects and complications of IVCY therapy.

AB - This long-term follow-up study evaluates the clinical efficacy, toxicity, and effects on renal histopathology of intravenous high dose cyclophosphamide (IVCY) therapy for severe active lupus nephritis patients. The clinical course and final outcome for each patient was evaluted by determining daily oral prednisolone dose. C3, C4, anti-dsDNA, Ccr, daily urine protein, serum albumin, hemoglobulin, blood urea nitrogen, creatinine and renal histopathology. This regimen resulted in significant improvement of daily prednisolone dosage, serum C3, C4, albumin, hemoglobulin and Ccr as early as the third month, and became further improved or stable through 24 months. The mean anti-dsDNA level, twenty-four-hour urine protein excretion, and serum urea nitrogen level showed statistical decrease at variable time course and there were no statistical changes in the serum creatinine level throughout this study. Renal biopsies were obtained in 10 out-of 11 patients at the beginning of treatment, and follow-up renal biopsies were performed in 7 out of 10 patients, and five patients showed improvement in histologic features and had predominent Class II. Even this was an retrospective and uncontrolled study, intermittent IVCY therapy seemed to be an effective regimen for severe lupus nephritis. However, further investigation and regular follow-up are necessary to elucidate the long-term effects and complications of IVCY therapy.

UR - http://readopac1.ncl.edu.tw/nclJournal/search/detail.jsp?sysId=0005565061&dtdId=000040&search_type=detail&la=ch

UR - http://readopac1.ncl.edu.tw/nclJournal/search/summny_list.jsp?sysId=0005565061&dtdId=000040

M3 - Article

VL - 31

SP - 27

EP - 34

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

SN - 0253-2662

IS - 1

ER -